These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 15690685

  • 1. Resistance trends in Haemophilus influenzae (PROTEKT years 1-3 [1999-20021).
    Low DE.
    J Chemother; 2004 Dec; 16 Suppl 6():49-61. PubMed ID: 15690685
    [No Abstract] [Full Text] [Related]

  • 2. Resistance trends in Streptococcus pyogenes (PROTEKT years 1-3 [1999-2002]).
    Cohen R, Green M.
    J Chemother; 2004 Dec; 16 Suppl 6():71-82. PubMed ID: 15690687
    [No Abstract] [Full Text] [Related]

  • 3. PROTEKT years 1-3 (1999-2002): study design and methodology.
    Harding I, Felmingham D.
    J Chemother; 2004 Dec; 16 Suppl 6():9-18. PubMed ID: 15690682
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program.
    Gordon KA, Biedenbach DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2003 Aug; 46(4):285-9. PubMed ID: 12944021
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the Ketolide Telithromycin: results from the PROTEKT surveillance study (1999-2000).
    Reinert RR, Rodloff AC, Halle E, Baer W, Beyreiss B, Seifert H, Wichelhaus TA, Maass M, Mehl M.
    Chemotherapy; 2004 Jun; 50(3):143-51. PubMed ID: 15272227
    [Abstract] [Full Text] [Related]

  • 7. Introduction to PROTEkT: years 1-3 (1999-2002).
    Harding I.
    J Chemother; 2004 Dec; 16 Suppl 6():5-7. PubMed ID: 15690681
    [No Abstract] [Full Text] [Related]

  • 8. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
    Felmingham D.
    J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
    [Abstract] [Full Text] [Related]

  • 9. Introduction: PROTEKT against respiratory tract infection.
    Stratton CW.
    J Chemother; 2002 Jul; 14 Suppl 3():5-8. PubMed ID: 12418555
    [No Abstract] [Full Text] [Related]

  • 10. In vitro activity of tigecycline against ampicillin-resistant Haemophilus influenzae isolates.
    Betriu C, Gómez M, Rodríguez-Avial I, Culebras E, Picazo JJ.
    J Antimicrob Chemother; 2005 May; 55(5):809-10. PubMed ID: 15790670
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and antibacterial activity of 6-O-(heteroaryl-isoxazolyl)propynyl 2-fluoro ketolides.
    Sugimoto T, Shimazaki Y, Manaka A, Tanikawa T, Suzuki K, Nanaumi K, Kaneda Y, Yamasaki Y, Sugiyama H.
    Bioorg Med Chem Lett; 2012 Sep 01; 22(17):5739-43. PubMed ID: 22858102
    [Abstract] [Full Text] [Related]

  • 12. Resistant Haemophilus influenzae in community-acquired respiratory tract infections: a role for cefixime.
    Verhoef J, Gillissen A.
    Int J Antimicrob Agents; 2003 Jun 01; 21(6):501-9. PubMed ID: 12791462
    [Abstract] [Full Text] [Related]

  • 13. [Discussions on PRSP and BLNAR].
    Tajima T, Meguro H, Akita H, Iwata T.
    Jpn J Antibiot; 2001 May 01; 54 Suppl B():103; discussion 104-6. PubMed ID: 12638161
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: findings from the PROTEKT US study, 2000-2001.
    Stratton CW, Brown SD.
    Clin Ther; 2004 Apr 01; 26(4):522-30. PubMed ID: 15189749
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recent findings from multinational resistance surveys: are we 'PROTEKTed' from resistance?
    Marchese A, Schito GC.
    Int J Antimicrob Agents; 2007 Feb 01; 29 Suppl 1():S2-5. PubMed ID: 17307653
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.